Filing Details

Accession Number:
0000899243-20-017104
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-18 17:29:31
Reporting Period:
2020-06-16
Accepted Time:
2020-06-18 17:29:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1733294 Generation Bio Co. GBIO () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1534261 Casdin Capital, Llc 1350 Avenue Of The Americas
Suite 2600
New York NY 10019
No No Yes No
1534264 Eli Casdin 1350 Avenue Of The Americas
Suite 2600
New York NY 10019
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-16 961,215 $0.00 961,215 No 4 C Indirect See Footnote
Common Stock Acquisiton 2020-06-16 650,000 $19.00 1,611,215 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2020-06-16 1,093,410 $0.00 703,331 $0.00
Common Stock Series C Preferred Stock Disposition 2020-06-16 455,500 $0.00 257,883 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. On June 16, 2020, the Series B Preferred Stock automatically converted into Common Stock on approximately a 1.5546-for-one basis (when rounded to the nearest ten-thousandth) without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  2. On June 16, 2020, the Series C Preferred Stock automatically converted into Common Stock on a 1.7663-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  3. The securities are owned directly by clients of Casdin Capital, LLC and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC as investment adviser to such clients and (ii) Eli Casdin as managing member of Casdin Capital, LLC.